Position in ZNTL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$664,003
New position
Shares Held
283,762
first reported quarter
Ownership
0.399%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 100%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026CDC Financial, Inc. holds $9,036,154 across 2 Biotechnology names. ZNTL ranks #2 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
124,530 | $8,372,151 | |
| 2 | ZNTL |
Zentalis Pharmaceuticals, Inc.
This page
|
283,762 | $664,003 |
All Filings in ZNTL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $664,003 | 283,762 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||